From the Pages of AllergyWatch

• Type of Material: Article
• Authors: Stanley Fineman, Emory University; Gerald Lee, Emory University; Shyam Joshi, Oregon Health & Science University; Vivian Hernandez-Trujillo, Allergy & Immunoly Care Center South Florida
• Language: English
• Date: 2022-03-01
• Publisher: ELSEVIER SCIENCE INC
• Publication Version: Final Published Version
• Copyright Statement: © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
• Final Published Version (URL): http://dx.doi.org/10.1016/j.anai.2021.12.007
• Title of Journal or Parent Work: ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
• Volume: 128
• Issue: 3
• Start Page: 340
• End Page: 341
• Grant/Funding Information: The authors have no funding sources to report.
• Keywords: Life Sciences & Biomedicine; Immunology; Science & Technology; Allergy
• Research Categories: Health Sciences, Immunology

Abstract

For this edition of From the Pages of AllergyWatch, I have selected reviews from the July to August 2021 issue. The first article, with comments from Dr Lee, presents data from patients with mastocytosis who were able to receive their coronavirus disease 2019 (COVID-19) vaccinations after premedication. The next article, with comments from Dr Joshi, outlines a study investigating the risk of airborne peanut allergy triggering reactions in patients with peanut sensitivity. The third, with comments from Dr Hernandez-Trujillo, presents data from laboratory specimens illustrating that alpha-gal allergy is an increasing problem, especially in the South. Stanley Fineman, MD, Editor-in-Chief, Allergy Watch